Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes

BACKGROUND: In insulin-treated patients with type 2 diabetes mellitus (T2DM), glycemic control is usually suboptimal. METHODS: This study compared the risks of mortality and cardiovascular events in insulin-treated patients adding or not adding alpha-glucosidase inhibitors (AGIs). RESULTS: This coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Fu-Shun, Wei, James Cheng-Chung, Lin, Mei-Chen, Hsu, Chih-Cheng, Hwu, Chii-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890630/
https://www.ncbi.nlm.nih.gov/pubmed/33602190
http://dx.doi.org/10.1186/s12902-021-00690-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890630/
https://www.ncbi.nlm.nih.gov/pubmed/33602190
http://dx.doi.org/10.1186/s12902-021-00690-0

Ejemplares similares